LncRNA ENSMUST00000171502 Induced by HIF-1α Ameliorates Ischemic Acute Kidney Injury via Targeting the miR-130b-3p/Mybl-1 Axis.

Jinghong Xu, Bing Wang, Dongshan Zhang

Open access · goldAbstract read

In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

0.9field-weighted citation impact, top 27% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

miR-204-5p attenuates inflammatory infiltration in early-stage chronic renal allograft dysfunction by modulating the IL-11/ERK1/2-NF-κB axis.Frontiers in immunology · 2026
Article
Long Non-coding RNA MIR22HG Alleviates Ischemic Acute Kidney Injury by Targeting the miR-134-5p/NFAT5 axis.Inflammation · 2025
Article
The role of lncRNAs in AKI and CKD: Molecular mechanisms, biomarkers, and potential therapeutic targets.Genes & diseases · 2025
Review
Inhibition of Mettl3 alleviates low-dose cisplatin-induced renal fibrosis and enhances the chemotherapeutic efficacy in mouse models of cancer.International journal of biological sciences · 2025
Article
Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI.Journal of inflammation research · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jinghong XuDepartment of Emergency, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Bing WangDepartment of Spine Surgery, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Dongshan ZhangDepartment of Emergency, Second Xiangya Hospital, Central South University, Changsha 410011, China.

Central South University · CN

Funding

Changsha Science and Technology Bureau project kq2001039Key Project of Hunan provincial science and technology innovation 2020SK1014National Natural Science Foundation of China 81870475National Natural Science Foundation of China 81871748

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryMicroRNAsRNA, Long NoncodingAnimalsHypoxia-Inducible Factor 1, alpha SubunitMiceMice, Inbred C57BLOncogenesProto-Oncogene Proteins c-mybTrans-ActivatorsHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMicroRNAsMybl1 protein, mouseProto-Oncogene Proteins c-mybRNA, Long NoncodingTrans-ActivatorsAKIapoptosislncRNA171502miRNA-130b-3pMybl-1

Identifiers

PMID36497007

DOI10.3390/cells11233747

PMCPMC9735850

OpenAlexW4309845574

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.